Evidence map›Paper›PMID 21655214›Full record

ArticlePloS one2011

Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation.

Yira Bermudez, Claudia A Benavente, Ralph G Meyer, W Russell Coyle, Myron K Jacobson, Elaine L Jacobson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Butyrate: A Double-Edged Sword for Health?Advances in nutrition (Bethesda, Md.) · 2018
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yira BermudezArizona Cancer Center and Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, United States of America.
Claudia A Benavente
Ralph G Meyer
W Russell Coyle
Myron K Jacobson
Elaine L Jacobson
University of Arizona · US

Funding

SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
VITAMIN A, AND ITS PRECURSORS AND DERIVATIVES AS THERAPEUTIC MODALITIESP01CA027502 · NCI · UNIVERSITY OF ARIZONA · PI EINSPAHR, JANINE G · 1985 to 2015
$36.3M
Cancer Prevention and Control Translational ResearchR25CA078447 · NCI · UNIVERSITY OF ARIZONA · PI ALBERTS, DAVID SAMUEL · 1998 to 2014
$7.6M
ALTERATION OF NAD METABOLISM BY CHEMICAL CARCINOGENSR01CA043894 · NCI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI JACOBSON, MYRON K · 1986 to 2008
$2.8M
Endogenous photosensitizers in skin carcinogenesisR01CA106677 · NCI · UNIVERSITY OF ARIZONA · PI JACOBSON, ELAINE L · 2005 to 2009
$1.6M
ADP-Ribose Polymer Metabolism in SpermatogenesisR01HD048837 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI MEYER, RALPH G · 2005 to 2009
$1.4M
Cancer Prevention and Control Health Disparities Training ProgramT32CA078447 · NCI · UNIVERSITY OF ARIZONA · PI ALBERTS, DAVID SAMUEL, HARRIS, ROBIN B · 2016 to 2020
$1.2M
NCI NIH HHS CA027502NCI NIH HHS CA106677NCI NIH HHS CA43894NCI NIH HHS CA78447NCI NIH HHS P01 CA027502NCI NIH HHS R01 CA043894NCI NIH HHS R01 CA106677NCI NIH HHS R25 CA078447NCI NIH HHS T32 CA078447NICHD NIH HHS HD048837NICHD NIH HHS R01 HD048837NIEHS NIH HHS ES06694NIEHS NIH HHS P30 ES006694
6 · The paper itself

Abstract

backgroundChronic UV skin exposure leads to epidermal differentiation defects in humans that can be largely restored by pharmacological doses of nicotinic acid. Nicotinic acid has been identified as a ligand for the human G-protein-coupled receptors GPR109A and GPR109B that signal through G(i)-mediated inhibition of adenylyl cyclase. We have examined the expression, cellular distribution, and functionality of GPR109A/B in human skin and skin derived epidermal cells.

resultsNicotinic acid increases epidermal differentiation in photodamaged human skin as judged by the terminal differentiation markers caspase 14 and filaggrin. Both GPR109A and GPR109B genes are transcribed in human skin and in epidermal keratinocytes, but expression in dermal fibroblasts is below limits of detection. Receptor transcripts are greatly over-expressed in squamous cell cancers. Receptor protein in normal skin is prominent from the basal through granular layers of the epidermis, with cellular localization more dispersive in the basal layer but predominantly localized at the plasma membrane in more differentiated epidermal layers. In normal human primary and immortalized keratinocytes, nicotinic acid receptors show plasma membrane localization and functional G(i)-mediated signaling. In contrast, in a squamous cell carcinoma derived cell line, receptor protein shows a more diffuse cellular localization and the receptors are nearly non-functional.

conclusionsThe results of these studies justify future genetic and pharmacological intervention studies to define possible specific role(s) of nicotinic acid receptors in human skin homeostasis.

Indexed as

Cell DifferentiationCell LineCell Line, TumorCell MembraneCells, CulturedCyclic AMPFilaggrin ProteinsHumansImmunoblottingImmunohistochemistryKeratinocytesNiacinReceptors, G-Protein-CoupledReceptors, NicotinicReverse Transcriptase Polymerase Chain ReactionSkinCyclic AMPFilaggrin ProteinsFLG protein, humanHCAR2 protein, humanHCAR3 protein, humanNiacinReceptors, G-Protein-CoupledReceptors, Nicotinic

Identifiers

PMID21655214
PMCPMC3105069
OpenAlexW2140143326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.